1. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial. Issue 10184 (11th May 2019) Authors: Heerspink, Hiddo J L; Parving, Hans-Henrik; Andress, Dennis L; Bakris, George; Correa-Rotter, Ricardo; Hou, Fan-Fan; Kitzman, Dalane W; Kohan, Donald; Makino, Hirofumi; McMurray, John J V; Melnick, Joel Z; Miller, Michael G; Pergola, Pablo E; Perkovic, Vlado; Tobe, Sheldon; Yi, Tingting; Wigderso... Journal: Lancet Issue: Volume 393:Issue 10184(2019) Page Start: 1937 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study. Issue 5 (May 2023) Authors: Menzies-Gow, Andrew; Wechsler, Michael E; Brightling, Christopher E; Korn, Stephanie; Corren, Jonathan; Israel, Elliot; Chupp, Geoffrey; Bednarczyk, Artur; Ponnarambil, Sandhia; Caveney, Scott; Almqvist, Gun; Gołąbek, Monika; Simonsson, Linda; Lawson, Kaitlyn; Bowen, Karin; Colice, Gene; Hetzel, ... Journal: Lancet Issue: Volume 11:Issue 5(2023) Page Start: 425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. O10 ‐ Rupatadine is effective and safe in the treatment of Chronic Spontaneous Urticaria (CSU) in pediatric patients (2‐11 years old). (28th February 2014) Authors: Potter, Paul; Mitha, Essack; Barkai, Laszlo; Domenech, Alejandro; Santamaria, Eva; Giralt, Josep; Izquierdo, Iñaki; Maurer, Marcus Journal: Clinical and translational allergy Issue: Volume 4(2014)supplement 1 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254 . (6th January 2022) Authors: Spinner, Christoph D; Felizarta, Franco; Rizzardini, Giuliano; Philibert, Patrick; Mitha, Essack; Domingo, Pere; Stephan, Christoph J; DeGrosky, Michelle; Bainbridge, Veronica; Zhan, Joyce; Dumitrescu, Teodora Pene; Jeffrey, Jerry L; Xu, Jianfeng; Halliday, Fiona; Gan, Jianjun; Johnson, Mark; Gar... Journal: Clinical infectious diseases Issue: Volume 75:Number 5(2022) Page Start: 786 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2–11 years. Issue 1 (12th November 2015) Authors: Potter, Paul; Mitha, Essack; Barkai, László; Mezei, Györgyi; Santamaría, Eva; Izquierdo, Iñaki; Maurer, Marcus Journal: Pediatric allergy and immunology Issue: Volume 27:Issue 1(2016) Page Start: 55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Single dose Peramivir for the Treatment of Acute Seasonal Influenza: Integrated Analysis of Efficacy and Safety from Two Placebo-Controlled Trials. Issue 7 (October 2015) Authors: Whitley, Richard; Laughlin, Alan; Carson, Simon; Mitha, Essack; Tellier, Guy; Stich, Mark; Elder, Jenna; Alexander, W James; Dobo, Sylvia; Collis, Phil; Sheridan, William P Journal: Antiviral therapy Issue: Volume 20:Issue 7(2015) Page Start: 709 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Week 96 extension results of a Phase 3 study evaluating long-acting cabotegravir with rilpivirine for HIV-1 treatment. (1st February 2022) Authors: Swindells, Susan; Lutz, Thomas; Van Zyl, Lelanie; Porteiro, Norma; Stoll, Matthias; Mitha, Essack; Shon, Alyssa; Benn, Paul; Huang, Jenny O.; Harrington, Conn M.; Hove, Kai; Ford, Susan L.; Talarico, Christine L.; Chounta, Vasiliki; Crauwels, Herta; Van Solingen-Ristea, Rodica; Vanveggel, Simon; ... Journal: AIDS Issue: Volume 36:Number 2(2022) Page Start: 185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Week 96 extension results of a Phase 3 study evaluating long-acting cabotegravir with rilpivirine for HIV-1 treatment. (1st February 2022) Authors: Swindells, Susan; Lutz, Thomas; Van Zyl, Lelanie; Porteiro, Norma; Stoll, Matthias; Mitha, Essack; Shon, Alyssa; Benn, Paul; Huang, Jenny O.; Harrington, Conn M.; Hove, Kai; Ford, Susan L.; Talarico, Christine L.; Chounta, Vasiliki; Crauwels, Herta; Van Solingen-Ristea, Rodica; Vanveggel, Simon; ... Journal: AIDS Issue: Volume 36:Number 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗